Literature DB >> 25607340

Clinical characteristics and predictive factors of subclinical diabetic nephropathy.

Y Zhang1, J Yang1, M Zheng1, Y Wang1, H Ren1, Y Xu1, Y Yang1, J Cheng1, F Han1, X Yang1, L Chen1, C Shan1, B Chang1.   

Abstract

BACKGROUND: To investigate the clinical characteristics and predictive factors of subclinical diabetic nephropathy in type 2 diabetes patients.
METHODS: A total of 298 type 2 diabetes patients were divided into 3 groups based on 24-h urinary microalbumin and estimated glomerular filtration rate: patients with normal albuminuria and glomerular filtration rate (NC), patients with normoalbuminuria and glomerular hyperfiltration (SDN) and patients with microalbuminuria (EDN). The renal size, tubular injury markers and ambulatory blood pressure were analyzed.
RESULTS: Renal size increased in the SDN and EDN groups compared to the NC group (P<0.05), while renal length in the SDN group was greater than the EDN group (P<0.05). Patients in the SDN and EDN groups had higher level of urine retinol binding protein and N-acetyl-β-D-glucosaminidase and most of them developed proximal tubular dysfunction. The SDN group had higher 24-h mean and nocturnal diastolic blood pressure than the NC group (P<0.05), while the EDN group had higher systolic blood pressure and pulse pressure than the SDN group (P<0.01). More patients developed abnormal blood pressure rhythm in the SDN and EDN groups. The likelihood of a decrease in nocturnal systolic blood pressure was lower as the microalbuminuria increased. Increased renal size, more abnormal tubular injury markers and higher 24-h mean and nocturnal blood pressure were all risk factors of subclinical diabetic nephropathy.
CONCLUSION: Patients with subclinical diabetic nephropathy had increased renal size, abnormal tubular injury markers, high blood pressure and abnormal circadian rhythm. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 25607340     DOI: 10.1055/s-0034-1396810

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Pathological Hyperinsulinemia and Hyperglycemia in the Impaired Glucose Tolerance Stage Mediate Endothelial Dysfunction Through miR-21, PTEN/AKT/eNOS, and MARK/ET-1 Pathways.

Authors:  Ran Liu; Shilin Guan; Zhongai Gao; Jingyu Wang; Jie Xu; Zhaohu Hao; Yi Zhang; Shaohua Yang; Zhenhong Guo; Juhong Yang; Hailin Shao; Baocheng Chang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

2.  Hyperinsulinemia contributes to impaired-glucose-tolerance-induced renal injury via mir-7977/SIRT3 signaling.

Authors:  Zhongai Gao; Ziyan Wang; Hong Zhu; Xinxin Yuan; Mengdi Sun; Jingyu Wang; Minxia Zuo; Xiao Cui; Ying Han; Yi Zhang; Shaohua Yang; Yongzhang Qin; Jie Xu; Juhong Yang; Baocheng Chang
Journal:  Ther Adv Chronic Dis       Date:  2020-05-08       Impact factor: 5.091

3.  Hyperinsulinemia Can Cause Kidney Disease in the IGT Stage of OLETF Rats via the INS/IRS-1/PI3-K/Akt Signaling Pathway.

Authors:  Yi Zhang; Shaohua Yang; Xiao Cui; Juhong Yang; Miaoyan Zheng; Junya Jia; Fei Han; Xiaoyun Yang; Jingyu Wang; Zhenhong Guo; Bai Chang; Baocheng Chang
Journal:  J Diabetes Res       Date:  2019-10-13       Impact factor: 4.011

4.  Association of serum high-density lipoprotein cholesterol with microalbuminuria in type 2 diabetes patients.

Authors:  Xun Sun; Ye Xiao; Pei-Mei Li; Xiu-Yun Ma; Xiao-Jie Sun; Wen-Shan Lv; Yi-Li Wu; Peng Liu; Yan-Gang Wang
Journal:  Lipids Health Dis       Date:  2018-10-05       Impact factor: 3.876

5.  Renal impairment markers in type 2 diabetes patients with different types of hyperuricemia.

Authors:  Zhongai Gao; Minxia Zuo; Fei Han; Xinxin Yuan; Mengdi Sun; Xiaochen Li; Ran Liu; Wenhui Jiang; Liyi Zhang; Baocheng Chang; Juhong Yang
Journal:  J Diabetes Investig       Date:  2018-05-04       Impact factor: 4.232

6.  Evaluation of urinary biomarkers for prediction of diabetic kidney disease: a propensity score matching analysis.

Authors:  Yongzhang Qin; Shuang Zhang; Xiaofang Shen; Shunming Zhang; Jingyu Wang; Minxia Zuo; Xiao Cui; Zhongai Gao; Juhong Yang; Hong Zhu; Baocheng Chang
Journal:  Ther Adv Endocrinol Metab       Date:  2019-12-02       Impact factor: 3.565

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.